JESSICA WU: Open Payments
NPI 1265972301 · MONTEREY PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 34 payments from 16 companies in 2025. Trend: 2023 $970 · 2024 $1,301 · 2025 $886
Food & beverage: $886
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $220 |
| Abbott Laboratories | 2 | $105 |
| Amgen Inc. | 4 | $101 |
| GlaxoSmithKline, LLC. | 4 | $92 |
| Aimmune Therapeutics, Inc. | 2 | $55 |
| Dexcom, Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Novo Nordisk Inc | 2 | $36 |
| CONMED Corporation | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
Products named: Kerendia, FREESTYLE LIBRE 3, EVENITY, ZENPEP, Dexcom G6 Transmitter, SHINGRIX, CONMED BILIARY, LEQVIO.
Industry payments across CA — which companies pay providers there.
